Statistical Issues in Translational Cancer Research

作者: Stephen L. George

DOI: 10.1158/1078-0432.CCR-07-4537

关键词: PathologyResearch designRisk analysis (engineering)Neoplasms diagnosisOptimismMEDLINENeoplasms therapyClinical trialLaboratory resultsDiseaseMedicine

摘要: … translational cancer medicine. More detailed discussion of these and other statistical topics in clinical trials and in translational research can be found in various specialized texts (8–13). …

参考文章(36)
R. Spang, F. Markowetz, Molecular diagnosis. Classification, model selection and performance evaluation. Methods of Information in Medicine. ,vol. 44, pp. 438- 443 ,(2005) , 10.1055/S-0038-1633990
Richard M Simon, Edward L Korn, Lisa M McShane, Michael D Radmacher, George W Wright, Yingdong Zhao, Design and Analysis of DNA Microarray Investigations ,(2003)
David F. Ransohoff, Bias as a threat to the validity of cancer molecular-marker research Nature Reviews Cancer. ,vol. 5, pp. 142- 149 ,(2005) , 10.1038/NRC1550
David F. Ransohoff, Rules of evidence for cancer molecular-marker discovery and validation Nature Reviews Cancer. ,vol. 4, pp. 309- 314 ,(2004) , 10.1038/NRC1322
Daniel J. Sargent, Barbara A. Conley, Carmen Allegra, Laurence Collette, Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials Journal of Clinical Oncology. ,vol. 23, pp. 2020- 2027 ,(2005) , 10.1200/JCO.2005.01.112
Daniela Dunkler, Stefan Michiels, Michael Schemper, Gene expression profiling: Does it add predictive accuracy to clinical characteristics in cancer prognosis? European Journal of Cancer. ,vol. 43, pp. 745- 751 ,(2007) , 10.1016/J.EJCA.2006.11.018